Key Record Dates
ClinicalTrials.gov Identifier: | NCT03346434 |
---|---|
Brief Title: | Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) (Liberty AD) |
First Submitted : | February 6, 2017 |
First Submitted that Met QC Criteria : | November 14, 2017 |
First Posted : | November 17, 2017 |
Results First Submitted : | June 14, 2022 |
Results First Posted with QC Comments : | July 11, 2022 |
Results First Submitted that Met QC Criteria : | July 27, 2022 |
Results First Posted : | July 28, 2022 |
Last Update Submitted that Met QC Criteria : | July 27, 2022 |
Last Update Posted : | July 28, 2022 |